11/01/2024
5:43 PM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:15 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
3:20 PM | Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:21 PM | Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
2:22 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
2:16 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
3:13 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/08/2024
6:06 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
6:02 AM | Apellis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/21/2024
6:34 PM | Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:50 PM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
7:09 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
4:15 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
4:13 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
6:02 AM | Apellis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/19/2024
6:27 PM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
3:25 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:17 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
10:24 AM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
4:18 PM | Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
11:53 AM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
2:22 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024
3:36 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
6:45 AM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
12:37 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:10 PM | Apellis Pharmaceuticals (Filer)
| Form 10-K/A | |
02/27/2024
6:35 AM | Apellis Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
6:30 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
6:01 AM | Apellis Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
4:18 PM | Apellis Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
8:23 AM | Apellis Pharmaceuticals (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
02/12/2024
2:19 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:22 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:27 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:28 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:43 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
2:46 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
3:34 PM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:36 PM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:38 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:23 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
We recommended Nvidia in 2016, now we’re recommending this… (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
01/31/2024
3:26 PM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:28 PM | Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:31 PM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
9:50 AM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
9:04 AM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:15 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:15 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:16 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:16 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:17 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:19 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
6:28 PM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:13 PM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:15 PM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:17 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:00 PM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:01 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:03 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:05 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:07 PM | Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
5:11 PM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
11:36 AM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
9:21 AM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:33 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:34 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:14 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:18 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:18 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:19 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:21 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:21 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:21 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
2:23 PM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
7:00 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
3:54 PM | Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:55 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:47 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:37 PM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:38 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:40 PM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:41 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:43 PM | Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:45 PM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:32 PM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:33 PM | Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:36 PM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
11:24 AM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
9:46 AM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
9:18 AM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:48 PM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
We recommended Nvidia in 2016, now we’re recommending this… (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
01/16/2024
2:49 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:50 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:51 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:53 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:41 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:44 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:44 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
2:47 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
8:07 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
